DeVita: It Was Time To Go, and The Action Is Not A Memorial: Says He’ll Work Well With Paul Marks
In Brief: Senate Tracks Reauthorization n New Institute Bill, Waxman May Go Along: Abe Goldin Dies
DeVita Era At NCI One Of New Programs, Remarkable Stability
NCI Facing Extended Tie Under Acting Director – Maybe
ONS Opposes AMA On “Registered Care Technologist”
NIGMS Awards First Grants For Gene Mapping
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO
